Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy
- 14 November 2008
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 33 (3) , 551-558
- https://doi.org/10.1183/09031936.00123608
Abstract
Respiratory acidosis can become a serious problem during protective ventilation of severe lung failure. A pumpless arteriovenous interventional lung assist (iLA) for extracorporeal carbon dioxide removal has been used increasingly to control critical respiratory situations. The present study sought to evaluate the factors determining the efficacy of iLA and calculate its contribution to gas exchange.In a cohort of 96 patients with severe acute respiratory distress syndrome, haemodynamic parameters, oxygen consumption and carbon dioxide production as well as gas transfer through the iLA were analysed.The measurements demonstrated a significant dependency of blood flowviathe iLA device on cannula size (mean±sd1.59±0.52 L·min−1for 15 French (Fr), 1.94±0.35 L·min−1for 17 Fr, and 2.22 ±0.45 L·min−1for 19 Fr) and on mean arterial pressure. Oxygen transfer capacity averaged 41.7±20.8 mL·min−1, carbon dioxide removal was 148.0±63.4 mL·min−1. Within two hours of iLA treatment, arterial oxygen partial pressure/inspired oxygen fraction ratio increased significantly and a fast improvement in arterial carbon dioxide partial pressure and pH was observed.Interventional lung assist eliminates ∼50% of calculated total carbon dioxide production with rapid normalisation of respiratory acidosis. Despite limited contribution to oxygen transfer it may allow a more protective ventilation in severe respiratory failure.Keywords
This publication has 27 references indexed in Scilit:
- Pumpless extracorporeal carbon dioxide removal for life-threatening asthmaCritical Care Medicine, 2007
- Experimental safety and efficacy evaluation of an extracorporeal pumpless artificial lung in providing respiratory support through the axillary vesselsThe Journal of Thoracic and Cardiovascular Surgery, 2007
- A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia*Critical Care Medicine, 2006
- Extracorporeal support and patient outcome: Credible causality remains elusive*Critical Care Medicine, 2006
- Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLungThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assistBritish Journal of Anaesthesia, 2006
- Pumpless extracorporeal lung assist – experience with the first 20 casesEuropean Journal of Cardio-Thoracic Surgery, 2000
- A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill PatientsNew England Journal of Medicine, 1995
- Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1994
- Prolonged Extracorporeal Oxygenation for Acute Post-Traumatic Respiratory Failure (Shock-Lung Syndrome)New England Journal of Medicine, 1972